Roche announced last week the launch of FoundationOne CDx, Foundation Medicines comprehensive companion diagnostic test for personalised cancer care in Singapore. According to the official media release, FoundationOne CDx supports clinicians in their decision-making by providing a clear, in-depth report that describes the unique genomic profile of a patients tumour as well as associated, approved therapies and relevant clinical trials.

Source: Click here